Publicacións (95) Publicacións nas que participase algún/ha investigador/a

2021

  1. A Bayesian Model to Predict COVID-19 Severity in Children

    Pediatric Infectious Disease Journal, Vol. 40, Núm. 8, pp. E287-E293

  2. AB0396 Rapid Improvement in Cystoid Macular Edema With High Dose Intravenous Methylprednisolone in Non-Infectious Uveitis ff Different Immune Mediated Inflammatory Diseases

    Annals of the Rheumatic Diseases, Vol. 80, Núm. Suppl 1, pp. 1225.3-1226

  3. AB0771 High Dose Intravenous Methylprednisolone Induces Rapid Improvement of Visual Acuity in Non-Infectious Uveitis of Different Immune Mediated Inflammatory Diseases

    Annals of the Rheumatic Diseases, Vol. 80, Núm. Suppl 1, pp. 1412.1-1412

  4. Acenocoumarol pharmacogenetic dosing algorithm versus usual care in patients with venous thromboembolism: A randomised clinical trial

    Journal of Clinical Medicine, Vol. 10, Núm. 13

  5. Arguments in favour of excluding MDBGN from the European baseline series. In response to “Comment on MDBGN/DBDCB, the European baseline series, and EU legislation”

    Contact Dermatitis

  6. Article a multicenter analysis of the outcome of cancer patients with neutropenia and covid-19 optionally treated with granulocyte-colony stimulating factor (G-csf): A comparative analysis

    Cancers, Vol. 13, Núm. 16

  7. Autoantibody screening in Guillain–Barré syndrome

    Journal of Neuroinflammation, Vol. 18, Núm. 1

  8. COVID-19 in hospitalized HIV-positive and HIV-negative patients: A matched study

    HIV Medicine, Vol. 22, Núm. 9, pp. 867-876

  9. COVID-19 pandemic. What have we learned?

    Anales de Pediatria, Vol. 95, Núm. 5, pp. 382.e1-382.e8

  10. Candidate Allergens for Inclusion in the Spanish Standard Series Based on Data from the Spanish Contact Dermatitis Registry

    Actas Dermo-Sifiliograficas, Vol. 112, Núm. 9, pp. 798-805

  11. Central apnea-hypopnea syndrome and Chiari malformation type 1: pre and post-surgical studies

    Sleep Medicine, Vol. 88, pp. 25-28

  12. Characteristics, clinical outcomes, and risk factors of SARS-COV-2 infection in adult acute myeloid leukemia patients: experience of the PETHEMA group

    Leukemia and Lymphoma, Vol. 62, Núm. 12, pp. 2928-2938

  13. Clinical Characteristics, Frailty, and Mortality of Residents With COVID-19 in Nursing Homes of a Region of Madrid

    Journal of the American Medical Directors Association, Vol. 22, Núm. 2, pp. 245-252.e2

  14. Clinical characteristics and outcomes of thymoma-associated myasthenia gravis

    European Journal of Neurology, Vol. 28, Núm. 6, pp. 2083-2091

  15. Clinical characterization and outcomes of 85 patients with neurosarcoidosis

    Scientific Reports, Vol. 11, Núm. 1

  16. Coexistence of immune-mediated diseases in sarcoidosis. Frequency and clinical significance in 1737 patients

    Joint Bone Spine, Vol. 88, Núm. 6

  17. Collateral damage in pediatric scenarios requiring urgent care during the covid-19 pandemic

    Emergencias

  18. Comparación entre la primera y la segunda ola de la pandemia producida por el coronavirus SARS-CoV-2 en urgencias pediátricas de un hospital terciario de Madrid

    Anales de Pediatría: Publicación Oficial de la Asociación Española de Pediatría ( AEP ), Vol. 95, Núm. 6, pp. 477-479

  19. Comparative study of formaldehyde 2% in aqueous solution vs TRUE Test in detecting formaldehyde sensitization

    Contact Dermatitis, Vol. 85, Núm. 3, pp. 358-359

  20. Contributions of the lupus register of the Spanish Society of Rheumatology (RELESSER) to the knowledge of systemic lupus erythematosus in Spain

    Reumatologia Clinica, Vol. 17, Núm. 5, pp. 245-249